4Filing Date: Sep 23, 2026

Gilead (GILD)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001927648-26-000005
Total Value$117.3K
Trades3
Insiders1

Transaction Details

Burkhart Erin
SVP, Controllership·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-2.22K
Price-
Total Value$0
Shares Owned After9.02K
Transaction DateSep 22, 2026
Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Burkhart Erin
SVP, Controllership·Direct
Exercise · Acquire
Common Stock
Shares+2.22K
Price-
Total Value$0
Shares Owned After2.22K
Transaction DateSep 22, 2026
Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Burkhart Erin
SVP, Controllership·Direct
Tax W/H · Dispose
Common Stock
Shares-768
Price$152.67
Total Value$117.3K
Shares Owned After1.46K
Transaction DateSep 22, 2026

Post-Transaction Holdings

Burkhart Erin · SVP, Controllership
SecuritySharesChange
Common Stock2.22K+1.46K (189.45%)
Restricted Stock Unit9.02K-2.22K (-19.77%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-22 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: Burkhart Erin CIK: 0001927648 Role: Officer (SVP, Controllership) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-22 | Code: M (Exercise of derivative) Shares: +2,223 Shares Owned After: 2,223 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [Transaction #2] Security: Common Stock Date: 2026-09-22 | Code: F (Payment of exercise/tax) Shares: -768 | Price: $152.67 Total Value: $117,250.56 Shares Owned After: 1,455 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-09-22 | Code: M (Exercise of derivative) Shares: -2,223 Shares Owned After: 9,022 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Footnotes (Complete Index) --- F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Erin E. Burkhart (2026-09-23)

keid analysis is for reference only and does not constitute investment advice.